HK EBUS (HKEB) 10-Q 20 Jan 15 2015 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Nov. 30, 2014	Jan. 19, 2015
Document and Entity Information:
EntityRegistrantName	RAMBO MEDICAL GROUP, INC.
EntityTradingSymbol	RAMB
DocumentType	10-Q
DocumentPeriodEndDate	30-Nov-14
AmendmentFlag	FALSE
EntityCentralIndexKey	1350421
CurrentFiscalYearEndDate	-26
EntityCommonStockSharesOutstanding		992,192
EntityFilerCategory	Smaller Reporting Company
EntityCurrentReportingStatus	Yes
EntityVoluntaryFilers	No
EntityWellKnownSeasonedIssuer	No
DocumentFiscalYearFocus	2015
DocumentFiscalPeriodFocus	Q2

CONDENSED_BALANCE_SHEETS

CONDENSED BALANCE SHEETS (USD $)	Nov. 30, 2014	31-May-14
Current assets
Cash	$4,926	$6,707
Total assets	4,926	6,707
Current liabilities
Net increase (decrease) in cash	791	791
Due to related party	88,859	88,859
Total current liabilities	89,650	89,650
Non-Current liabilities
Due to related party, net of current portion	40,000	20,000
Total liabilities	129,650	109,650
Stockholders' equity
Preferred stock, $.00001 par value; 100,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock, $.00001 par value; 300,000,000 authorized; 992,192 shares issued and outstanding as of November 30, 2014 and May 31, 2014	991	991
Additional paid in capital	7,043,222	7,043,222
Accumulated deficit	-7,168,937	-7,147,156
Total stockholders' deficit	-124,724	-102,943
Total liabilities and stockholders' deficit	$4,926	$6,707

BALANCE_SHEET_PARENTHETICALS

BALANCE SHEET PARENTHETICALS (USD $)	Nov. 30, 2014	31-May-14
Parentheticals
Preferred Stock, par value	$0.00	$0.00
Preferred Stock, shares authorized	100,000,000	100,000,000
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	300,000,000	300,000,000
Common Stock, shares issued	992,192	992,192
Common Stock, shares outstanding	992,192	992,192

CONDENSED_STATEMENTS_OF_OPERAT

CONDENSED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013	Nov. 30, 2014	Nov. 30, 2013
Revenue:
Revenue	$0	$0	$0	$0
Operating expenses
General and administrative expenses	18,042	14,270	21,781	30,396
Total operating expenses	18,042	14,270	21,781	30,396
Loss from operations	-18,042	-14,270	-21,781	-30,396
Net loss	($18,042)	($14,270)	($21,781)	($30,396)
Basic and diluted loss per common shares	($0.02)	($0.01)	($0.02)	($0.03)
Weighted average shares outstanding	992,192	992,192	992,192	992,192

CONDENSED_STATEMENTS_OF_CASH_F

CONDENSED STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Operating Activities:
Net loss	($21,781)	($30,396)
Changes operating assets and liabilities:
Accounts payable	0	24,559
Due to related party	20,000	11,000
Net cash provided by (used in) operating activities	-1,781	5,163
Net increase (decrease) in cash	-1,781	5,163
Cash at the beginning of period	6,707	4,458
Cash at the end of period	4,926	9,621
Supplemental disclosures of cash flow Information:
Cash paid for income taxes	$0	$0

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Nov. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Rambo Medical Group, Inc., formerly known as Viper Resources, Inc., was incorporated in the State of Nevada on November 18, 2005. On October 14, 2009, the Company filed a Certificate of Amendment to its Articles of Incorporation to increase its shares of authorized common stock from 100,000,000 to 300,000,000 and to change its name from Cobra Oil and Gas Company to Viper Resources, Inc. The Company was formed to engage in identifying, investigating, exploring, and where determined advantageous, developing, mining, refining, and marketing oil and gas. The Company may also engage in any other business permitted by law, as designated by the Board of Directors of the Company. On April 25, 2011, the Company’s previous management was replaced in its entirety. The Company’s new management term is currently evaluating the Company’s business operations and plans to make a determination on whether the Company will continue operating in the oil and gas industry.

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	6 Months Ended
	Nov. 30, 2014
BASIS OF PRESENTATION
BASIS OF PRESENTATION	NOTE 2. BASIS OF PRESENTATION
	The accompanying condensed balance sheet as of November 30, 2014, which has been derived from the Company's financial statements as of that date, and the unaudited condensed financial information of the Company as of November 30, 2014 and for the three and six months ended November 30, 2014 and 2013, has been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 8-03 of Regulation S-X. In the opinion of management, such financial information includes all adjustments considered necessary for a fair presentation of the Company's financial position at such date and the operating results and cash flows for such periods. Operating results for the interim period ended November 30, 2014 are not necessarily indicative of the results that may be expected for the entire year.
	Certain information and footnote disclosure normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the United States Securities and Exchange Commission ("SEC"). These unaudited condensed financial statements should be read in conjunction with our audited financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended May 31, 2014 filed on September 15, 2014 with the Securities Exchange Commission.

CASH_AND_CASH_EQUIVALENTS

CASH AND CASH EQUIVALENTS	6 Months Ended
	Nov. 30, 2014
CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS	NOTE 3. CASH AND CASH EQUIVALENTS
	The Company's cash balance is with local and national banking institutions and subjected to current FDIC insurance limits of $250,000 per banking institution. As of November 30, 2014 and May 31, 2014, the Company bank balances in the bank account did not exceed the insured amount.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Nov. 30, 2014
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 4. RELATED PARTY TRANSACTIONS
	On November 4, 2013, the company took a loan from American Compass Inc. (“ACI”), in the amount of $10,000. This is a no interest bearing and unsecured loan due on November 4, 2015. On April 17, 2014, the Company accepted another loan from ACI in the amount of $10,000. This is a non-interest bearing and unsecured loan due on April 17, 2016. On November 19, 2014, the Company accepted another loan from ACI in the amount of $10,000. This is a non-interest bearing and unsecured loan due on November 19, 2016. As of November 30, 2014, the total balance of loan from ACI is $128,859.
	30-Nov-14
	Current	$	88,859
	2015		20,000
	2016		20,000
		$	128,859

COMMON_STOCK

COMMON STOCK	6 Months Ended
	Nov. 30, 2014
COMMON STOCK
COMMON STOCK	NOTE 5. COMMON STOCK
	The Company is authorized to issue 100,000,000 shares of preferred stock with par values in $.00001. The Company is also authorized to issue 300,000,000 shares of common stock with par values in $.00001. On May 6, 2008, the Company affected a forward split of 35 for each share of common stock. On July 20, 2010, the Company issued 50,000 shares of common stock to investors at a price of $2 per unit for a total of $100,000. The Company had issued a total of 0.15 million shares of common stock to compensate its officers during the fiscal year of 2012. In order to seek alternative business development and future merging and stock offering, the shareholders of Viper Resource Inc. approved to a 1:100 reverse stock split and change the name to Rambo Medical Group Inc. on August 8, 2013. There were 992,192 shares issued and outstanding as of November 30, 2014 and May 30, 2014 respectively.

OFFICE_LEASE

OFFICE LEASE	6 Months Ended
	Nov. 30, 2014
OFFICE LEASE
OFFICE LEASE	NOTE 6. OFFICE LEASE
	Since May 2011, the company has not had a formal office lease. The Company uses office space provided by one of its officers on a rent free basis.

NAME_CHANGE

NAME CHANGE	6 Months Ended
	Nov. 30, 2014
NAME CHANGE
NAME CHANGE	NOTE 7. NAME CHANGE
	On August 8, 2013, the Company is approved to change name to Rambo Medical Group, Inc. and a 1-for-100 reverse split of the outstanding common stocks. The accompanying financial statements and notes to the financial statements give retroactive effect to the reverse stock split for all periods presented.

GOING_CONCERN

GOING CONCERN	6 Months Ended
	Nov. 30, 2014
GOING CONCERN
GOING CONCERN	NOTE 8. GOING CONCERN
	The accompanying unaudited condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses since inception and had accumulated a deficit of $7,168,937 and a working capital deficiency of $84,724 as of November 30, 2014.
	The future of the Company is dependent upon its ability to obtain financing and upon future profitable operations from the development of its planned business. Management has plans to seek additional capital through a public or private offering of equity or debt securities, or by other means. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments that might arise from this uncertainty.

RECENTLY_ACCOUNTING_PRONOUNCEM

RECENTLY ACCOUNTING PRONOUNCEMENT	6 Months Ended
	Nov. 30, 2014
RECENTLY ACCOUNTING PRONOUNCEMENT
RECENTLY ACCOUNTING PRONOUNCEMENT	NOTE 9. RECENTLY ACCOUNTING PRONOUNCEMENT
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-10, Development Stage Entities (Topic 915). ASU 2014-10 eliminates the distinction of a development stage entity and certain related disclosure requirements, including the elimination of inception-to-date information on the statements of operations, cash flows and stockholders’ equity. ASU 2014-10 is effective prospectively for annual reporting periods beginning after December 15, 2014, and interim periods within those annual periods, however early adoption is permitted. The Company has elected to early adopt the provisions of ASU 2014-10 and has removed the related disclosures in the accompanying condensed consolidated financial statements and notes.

RELATED_PARTY_TRANSACTIONS_Tab

RELATED PARTY TRANSACTIONS (Tables)	6 Months Ended
	Nov. 30, 2014
SCHEDULE OF RELATED PARTY TRANSACTIONS
Schedule of Related Party Transactions
	30-Nov-14
	Current	$	88,859
	2015		20,000
	2016		20,000
		$	128,859

CASH_AND_CASH_EQUIVALENTS_Deta

CASH AND CASH EQUIVALENTS (Details) (USD $)	Nov. 30, 2014
CASH AND CASH EQUIVALENTS DETAILS
Current FDIC insurance limits per banking institution	$250,000

RELATED_PARTY_TRANSACTIONS_Det

RELATED PARTY TRANSACTIONS (Details) (USD $)	Nov. 30, 2014	Nov. 19, 2014	Apr. 17, 2014	Nov. 04, 2013
RELATED PARTY TRANSACTIONS:
Loan from American Compass Inc.,				$10,000
Accepted another loan from American Compass Inc		10,000	10,000
Balance of the loans from ACI Current	88,859
Balance of the loans from ACI 2015	20,000
Balance of the loans from ACI 2016	20,000
Total balance of the loans from ACI	$128,859

COMMON_STOCK_TRANSACTIONS_Deta

COMMON STOCK TRANSACTIONS (Details) (USD $)	Nov. 30, 2014	31-May-14	6-May-08
COMMON STOCK TRANSACTIONS:
Preferred stock shares issued	100,000,000
Preferred stock shares par value	$0.00
Common stock issued shares	300,000,000		5,000,000
Common stock shares par value	$0.00		$2
Common stock shares value			$100,000
Shares issued and outstanding	992,192	992,192

GOING_CONCERN_Details

GOING CONCERN (Details) (USD $)	Nov. 30, 2014
GOING CONCERN DETAILS
Operating losses and accumulated deficit	$7,168,937
Working capital deficiency	$84,724